XML 27 R7.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities:      
Net income $ 149,267 $ 197,577 $ 161,152
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization of property, equipment, and intangibles 283,948 268,549 237,936
Amortization of debt issuance costs, original issue discount, and other 1,333 5,937 10,407
Gain on disposal of property and equipment, less write-off of totaled tractors (15,854) (30,195) (23,236)
Gain on sale of real property 0 0 (3,018)
Impairments 807 1,480 2,308
Deferred income taxes (36,079) 26,476 (3,980)
Provision (Reduction) (1,147) 8,004 2,844
Non-cash loss on debt extinguishment and write-offs of deferred financing costs and original issue discount 0 9,567 11,994
Stock-based compensation expense 6,017 6,525 5,396
Excess tax benefit from stock-based compensation (2,575) (2,147) (3,730)
Income effect of mark-to-market adjustment of interest rate swaps 0 87 (155)
Increase (decrease) in cash resulting from changes in:      
Accounts receivable 14,975 48,574 (63,407)
Inventories and supplies 1,796 566 (562)
Prepaid expenses and other current assets 20,999 17,741 17,802
Other assets 1,171 7,785 14,745
Accounts payable, and accrued and other liabilities 41,654 2,972 29,285
Net cash provided by operating activities 466,312 569,498 395,781
Cash flows from investing activities:      
(Increase) decrease in cash and cash equivalents — restricted (1,805) (9,620) 5,212
Proceeds from maturities of investments 30,269 33,015 29,783
Purchases of investments (30,061) (31,930) (28,921)
Proceeds from sale of property and equipment 113,410 116,330 133,020
Capital expenditures (239,446) (342,615) (305,966)
Payments received on notes receivable 10,114 4,252 5,481
Expenditures on assets held for sale (31,027) (25,937) (4,053)
Payments received on assets held for sale 25,939 14,410 25,326
Payments received on equipment sale receivables 0 288 368
Net cash used in investing activities (122,607) (241,807) (139,750)
Cash flows from financing activities:      
Repayment of long-term debt and capital leases (246,829) (979,816) (1,224,628)
Proceeds from long-term debt 0 684,504 900,000
Net (repayments) borrowings on revolving line of credit (70,000) 143,000 40,000
Borrowings under accounts receivable securitization 105,000 75,000 119,000
Repayment of accounts receivable securitization (50,000) (184,000) (49,000)
Payment of deferred loan costs 0 (4,235) (11,783)
Proceeds from common stock issued 14,469 8,167 12,604
Repurchase of Class A common stock (117,119) (70,000) 0
Excess tax benefits from stock-based compensation 2,575 2,147 3,730
Net cash used in financing activities (361,904) (325,233) (210,077)
Net (decrease) increase in cash and cash equivalents (18,199) 2,458 45,954
Cash and cash equivalents at beginning of period 107,590 105,132 59,178
Cash and cash equivalents at end of period 89,391 107,590 105,132
Cash paid during the period for:      
Interest 29,150 45,390 89,341
Income taxes 79,250 78,522 82,776
Non-cash investing activities:      
Equipment purchase accrual 11,103 447 35,831
Notes receivable from sale of assets 4,158 7,670 5,431
Equipment sales receivables 0 0 288
Non-cash financing activities:      
Capital lease additions 12,811 145,338 101,581
Accrued deferred loan costs 0 105 177
Insurance premium notes payable $ 8,430 $ 7,658 $ 37